EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model

Yoon Seok Nam, Eun-Ji Gi, Yoo-Seung Ko, Sungsu Lee iD, Hyong-Ho Cho iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0316033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Yoon Seok Nam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju, Rep…. Hauptthemen laut MEDLINE: Oxidative Stress, Nephritis, Hereditary, Hydroxamic Acids, Hearing Loss. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chonnam National University Hospital Biomedical Research Institute grant, Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, Commercialization’s Promotion Agency for R&D Outcomes (COMPA) grant funded by the Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alport syndrome (AS) is a genetic disorder marked by mutations in type IV collagen, leading to kidney glomerular dysfunction. AS also involves the cochlea, causing late-onset progressive hearing loss. Currently, there are no therapeutic drugs to protect hearing from AS. HDAC inhibitors (HDACis) are chemical compounds that block the activity of histone deacetylase and are known to exert diverse biologic effects. We investigated the effect of Trichostatin A (TSA), an HDACi, to assess its potential to inhibit hearing deterioration in AS. Col4a3 knockout (KO) mice were treated with TSA at 3 weeks of age, and hearing levels were measured using auditory brainstem response (ABR). The results demonstrate that TSA significantly protects the hearing of KO mice compared to the untreated group. The TSA-treated group exhibited a reduction in the levels of oxidative stress markers 4-Hydroxynonenal and 3-Nitrotyrosine, along with a decrease in inflammatory cytokines, in both the mouse cochlea and in vitro HEI-OC1 (House Ear Institute-Organ of Corti 1) cell and HEK (Human Embryonic Kidney)293T cells. AS demonstrated a thickening in the stria vascular vessels, a phenomenon that TSA attenuated. Col4α3 deficiency showed down-regulation of Hemeoxygenase-1 (HO-1), a key anti-inflammatory molecule. TSA treatment induced HO-1 signaling, which contributed to the inhibition of oxidative stress and inflammatory cytokines. These findings suggest that TSA represents a promising candidate molecule for mitigating the progression of hearing loss in AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressNephritis, HereditaryHydroxamic AcidsHearing LossInflammationHistone Deacetylase InhibitorsAnimalsMiceCollagen Type IVHumansDisease Models, AnimalMice, KnockoutEvoked Potentials, Auditory, Brain StemHEK293 CellsAutoantigensCochleaCytokinesMaleAldehydes

Substanzen

Hydroxamic Acidstrichostatin ACollagen Type IVHistone Deacetylase Inhibitorstype IV collagen alpha3 chainAutoantigensCytokines4-hydroxy-2-nonenalAldehydes

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju, Republic of Korea.
  • Department of Biomedical Science, College of Medicine, Chonnam National University Graduate School, BK21 PLUS Center for Creative Biomedical Scientists at Chonnam National University, Gwangju, Republic of Korea.

ORCID-Profile: Sungsu Lee, Hyong-Ho Cho

Förderung

  • Chonnam National University Hospital Biomedical Research Institute grant
  • Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology
  • Commercialization’s Promotion Agency for R&D Outcomes (COMPA) grant funded by the Korean government

Zitieren

APA

Nam, Y. S., Gi, E. J., Ko, Y. S., Lee, S., & Cho, H. H. (2025). Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model. PLOS ONE. https://doi.org/10.1371/journal.pone.0316033

Vancouver

Nam YS, Gi EJ, Ko YS, Lee S, Cho HH. Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model. PLOS ONE. 2025. doi:10.1371/journal.pone.0316033

BibTeX
@article{Nam2025,
  author = {Nam, Yoon Seok and Gi, Eun-Ji and Ko, Yoo-Seung and Lee, Sungsu and Cho, Hyong-Ho},
  title = {Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0316033}
}
Kostenlos starten →